# Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome

> **NCT04463212** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 62 (actual)

## Conditions studied

- Reversible Cerebral Vasoconstriction Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04463212
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-29
- **Primary completion:** 2024-01-12
- **Final completion:** 2024-01-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04463212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04463212, "Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04463212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*